The Automation Partnership Sells First ambr(TM) System to Global Antibody Therapeutics Company

CAMBRIDGE, UK--(BUSINESS WIRE)--The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, today announced it has sold its first advanced micro bioreactor system (ambr™) system to a global antibody therapeutics company, where ambr is being used to help predict how antibody expressing cell lines will behave in large scale bioreactors.

MORE ON THIS TOPIC